Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
Future Oncology (London, England)
|
April 25, 2025
Plain language summary: how long do patients with metastatic castration-resistant prostate cancer (mCRPC) live when taking abiraterone or enzalutamide in the real world?
Daniel J George, Krishnan Ramaswamy, Hongbo Yang, et al.
Plos One
|
January 6, 2022
Pandemic-related declines in hospitalization for non-COVID-19-related illness in the United States from January through July 2020
Jennifer L Nguyen, Michael Benigno, Deepa Malhotra, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
July 8, 2022
Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database
Muhammad Bilal Munir, Patrick Hlavacek, Allison Keshishian, et al.
Seizure
|
July 22, 2011
An open-label, add-on study of pregabalin in patients with partial seizures: a multicenter trial in Greece
Stefanos Tsounis, Vasilios K Kimiskidis, Dimitrios Kazis, et al.
Plos One
|
February 17, 2022
Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database
Muhammad Bilal Munir, Patrick Hlavacek, Allison Keshishian, et al.
Circulation. Cardiovascular Quality and Outcomes
|
November 2, 2021
Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration
Alexander C Perino, Jun Fan, Susan Schmitt, et al.
Breast Cancer Research : BCR
|
March 25, 2021
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice
Angela DeMichele, Massimo Cristofanilli, Adam Brufsky, et al.
JAMA Network Open
|
December 9, 2024
Physician Reasons for or Against Treatment Intensification in Patients With Metastatic Prostate Cancer
Neeraj Agarwal, Daniel J George, Zachary Klaassen, et al.
International Journal of Clinical Practice
|
November 21, 2020
Increasing access to erectile dysfunction treatment via pharmacies to improve healthcare provider visits and quality of life: Results from a prospective real-world observational study in the United Kingdom
Lauren J Lee, Terence A Maguire, Martine C Maculaitis, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2022
Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health Network
Jeanna Wallenta Law, Debanjali Mitra, Henry G Kaplan, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
Future Oncology (London, England)
|
April 25, 2025
Plain language summary: how long do patients with metastatic castration-resistant prostate cancer (mCRPC) live when taking abiraterone or enzalutamide in the real world?
Daniel J George, Krishnan Ramaswamy, Hongbo Yang, et al.
Plos One
|
January 6, 2022
Pandemic-related declines in hospitalization for non-COVID-19-related illness in the United States from January through July 2020
Jennifer L Nguyen, Michael Benigno, Deepa Malhotra, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
July 8, 2022
Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database
Muhammad Bilal Munir, Patrick Hlavacek, Allison Keshishian, et al.
Seizure
|
July 22, 2011
An open-label, add-on study of pregabalin in patients with partial seizures: a multicenter trial in Greece
Stefanos Tsounis, Vasilios K Kimiskidis, Dimitrios Kazis, et al.
Plos One
|
February 17, 2022
Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database
Muhammad Bilal Munir, Patrick Hlavacek, Allison Keshishian, et al.
Circulation. Cardiovascular Quality and Outcomes
|
November 2, 2021
Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration
Alexander C Perino, Jun Fan, Susan Schmitt, et al.
Breast Cancer Research : BCR
|
March 25, 2021
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice
Angela DeMichele, Massimo Cristofanilli, Adam Brufsky, et al.
JAMA Network Open
|
December 9, 2024
Physician Reasons for or Against Treatment Intensification in Patients With Metastatic Prostate Cancer
Neeraj Agarwal, Daniel J George, Zachary Klaassen, et al.
International Journal of Clinical Practice
|
November 21, 2020
Increasing access to erectile dysfunction treatment via pharmacies to improve healthcare provider visits and quality of life: Results from a prospective real-world observational study in the United Kingdom
Lauren J Lee, Terence A Maguire, Martine C Maculaitis, et al.
Current Oncology (Toronto, Ont.)
|
February 24, 2022
Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health Network
Jeanna Wallenta Law, Debanjali Mitra, Henry G Kaplan, et al.
Page
of 11